Dr. Mads Daugaard

Dr. Mads Daugaard

B.Sc. Biology, University of Copenhagen, Denmark 
M.Sc. Molecular Biology and Biochemistry, University of Copenhagen
Ph.D. Molecular Cancer Biology and Pathology, University of Copenhagen

Team: 
Clinical and Research Scientists
Positions: 

Senior Research Scientist, Vancouver Prostate Centre
Head, Molecular Pathology & Cell Imaging Core Facility, Vancouver Prostate Centre
Assistant Professor, Department of Urologic Sciences, University of British Columbia

 

Dr. Mads Daugaard is a molecular biologist specialized in tumour-associated stress signaling pathways and tumour targeting systems. He earned his PhD degree from the Faculty of Health Sciences, University of Copenhagen, for his studies on heat shock proteins in relation to cancer cell survival mechanisms. After completing his PhD, Dr. Daugaard received a junior fellowship award to continue his work at the Danish Cancer Society Research Centre on stress signaling pathways related to DNA damage response mechanisms. In 2010, Dr. Daugaard received a research award from the Danish Cancer Society Scientific Committee to do postdoctoral training in molecular pathology at the BC Cancer Research Centre and the Department of Pathology and Laboratory Medicine, University of British Columbia.

In 2014, Dr. Daugaard was recruited to the Vancouver Prostate Centre as a Senior Research Scientist and group leader. His ongoing research focuses on molecular and biochemical events underlying alternative polyadenylation of mRNAs, chromatin context-dependent DNA repair, development of resistance to chemotherapy, and immune-evasion mechanisms in cancer. Another aspect of Dr. Daugaard’s research relates to discovery and development of novel tumour targeting systems based on parasite-derived recombinant proteins relevant for therapeutic and diagnostic applications in cancer.

Dr. Daugaard has published original research in top-tier scientific journals and received competitive international funding support from institutions such as the US Department of Defense (DoD), Canadian Institutes of Health Research (CIHR), Stand Up 2 Cancer (SU2C), and Vancouver Coastal Health Research Institutes (VCHRI). In the 2014 competition, Dr. Daugaard received the Prostate Cancer Canada and Safeway Rising Star Award. Dr. Daugaard has served as an Editor of Cell Death & Disease (Nature Publishing Group) since 2016.

In 2012, Dr. Daugaard co-founded the biotechnology companies VAR2 Pharmaceuticals and OncoMal, and in 2017, the diagnostic company VarCT Diagnostics. Dr. Daugaard is elected Chairman of the Board of Directors in all three companies.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

VPC Terry Fox team 2016

Terry Fox Run: Sunday September 16, 2018

On Sunday September 16, the fundraising Terry Fox walk/run/ride is taking place across Canada.  We are grateful for our  grant support provided by The Terry Fox Foundation and Terry Fox Research Institute continously since 1998 - click here to donate to our team (opens in new window)

 

Vancouver

18th Annual Pacific Northwest Prostate Cancer Conference: Sat Sept 22, 2018

The 18th Annual Pacific Northwest Prostate Cancer Conference for patients, their families and health care professionals will be held in Vancouver on Saturday September 22, from 8 AM to 4 PM.  Click here for further details and to purchase tickets ($30, includes lunch). (Opens in new window)

 

Employment

Work at the Vancouver Prostate Centre

Thursday, July 26, 2018

Dr. Gleave awarded the 2018 Dr. Chew Wei Memorial Prize in Cancer Research

Dr. Gleave
Tuesday, May 29, 2018

Three VPC trainees receive 2018 VCHRI Rising Star Awards

2018 Rising Star Awardees
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.